Verified peer comparison
First Tracks Biotherapeutics vs GRAIL Financial Comparison
Direct answer
First Tracks Biotherapeutics and GRAIL are compared on the same basis.
The comparison uses 2024 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free First Tracks Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- First Tracks Biotherapeutics Revenue
- 0 USD
- GRAIL Revenue
- 125,595,000 USD
- First Tracks Biotherapeutics Operating income
- -181,101,000 USD
- GRAIL Operating income
- -2,189,158,000 USD